Wändell, P. http://orcid.org/0000-0001-5169-2965
Enarsson, M. A.
Feldreich, T.
Lind, L.
Ärnlöv, J. http://orcid.org/0000-0002-6933-4637
Carlsson, A. C.
Funding for this research was provided by:
Karolinska Institute
Article History
Accepted: 16 June 2024
First Online: 9 July 2024
Declarations
:
: All methods were conducted in accordance with relevant guidelines and regulations. The ULSAM study have ethical approvals from Regionala Etikprövningsnämnden EPN, Uppsala, Sweden.
: Informed consent was obtained from all subjects and/or participants. This manuscript contains no individual person’s data, and therefore can be published without consent from the participants.
: Johan Ärnlöv has received lecture fees from AstraZeneca and Novartis and served on advisory boards for AstraZeneca, Astella and Boehringer Ingelheim, all unrelated to the present project. No potential conflict of interest was reported by the other author(s).
: No potential conflict of interest was reported by the author(s).